AzTrials
AzTrials

Intubation; Difficult or FailedNCT06405672

The Effect of Endotracheal Tube With Stylet in Morbidly Obese Patients

A study testing Endotracheal tube with stylet and Endotracheal tube alone in people with Intubation; Difficult or Failed and Obesity, Morbid, run by Antalya Training and Research Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators aimed to compare the effects of using enotracheal tube with stylet versus endotracheal tube alone in morbidly obese patients undergoing sleeve gastrectomy. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Endotracheal tube with stylet and Endotracheal tube alone
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
30 Apr 2024to 30 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Body mass index over 30 ASA physical status I-III Undergoing laparoscopic sleeve gastrectomy -

Who cannot join

  • Body mass index under 30 ASA physical status IV Unable to cooperate Refused to give writtten informed consent-

Trial locations and contacts

No sites are listed yet.

Kerem İnanoğlu, MD contact

+902422494400

kinanoglu@yahoo.com

About this study

Official title: Comparison of Using an Endotracheal Tube With Stylet Versus an Endotracheal Tube Alone in Morbidly Obese Patients

The investigators aimed to compare the effects of using enotracheal tube with stylet versus endotracheal tube alone in morbidly obese patients undergoing sleeve gastrectomy.

Read the detailed description

Different intubation techniques have been used in morbidly obese patients undergoing general anesthesia. No study comparing the use of endotracheal tube with or without stylet was found in literature. Thus, the investigators aimed to compare the effects of using enotracheal tube with stylet versus endotracheal tube alone in morbidly obese patients undergoing sleeve gastrectomy.

Being tested
Endotracheal tube with stylet, Endotracheal tube alone
Keywords
different intubation techniques, endotracheal tube, obesity, stylet
Medical subject headings
Obesity, Morbid, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endotracheal tube with styletProcedure or surgery

    The obese patients who will be intubated with stylet in laparoscopic sleeve gastrectomy

  • Endotracheal tube aloneProcedure or surgery

    The obese patients who will be intubated without stylet in laparoscopic sleeve gastrectomy

Study groups in NCT06405672
Study groupRoleWhat they receive
Endotracheal tube with styletOtherThe obese patients who will be intubated with stylet in laparoscopic sleeve gastrectomy
Receives: Procedure: Endotracheal tube with stylet
Endotracheal tube aloneOtherThe obese patients who will be intubated without stylet in laparoscopic sleeve gastrectomy
Receives: Procedure: Endotracheal tube alone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubation time

    from handling laryngoscope to first vision of end-tidal CO2 waveform

    Measured: through study completion, an average of 6 months

Secondary outcomes (2)
  1. Intubation success

    success or failure of first intubation attempt

    Measured: through study completion, an average of 6 months

  2. complications

    Undesirable complications such as laryngospazm, hoarseness will be recorded at postoperative period

    Measured: through study completion, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2024
  2. Study start30 Apr 2024 (estimated)
  3. Primary completion30 Aug 2024 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06405672
Sponsor's protocol ID
1/17
Status last verified
Apr 2024
First submitted
30 Apr 2024
Last updated
8 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gaszynski T, Pietrzyk M, Szewczyk T, Gaszynska E. A comparison of performance of endotracheal intubation using the Levitan FPS optical stylet or Lary-Flex videolaryngoscope in morbidly obese patients. ScientificWorldJournal. 2014;2014:207591. doi: 10.1155/2014/207591. Epub 2014 May 20.

    PubMed 24967423
  • Nicholson A, Smith AF, Lewis SR, Cook TM. Tracheal intubation with a flexible intubation scope versus other intubation techniques for obese patients requiring general anaesthesia. Cochrane Database Syst Rev. 2014 Jan 17;2014(1):CD010320. doi: 10.1002/14651858.CD010320.pub2.

    PubMed 24443105

Questions about this trial

What is this clinical trial studying?

A study testing Endotracheal tube with stylet and Endotracheal tube alone in people with Intubation; Difficult or Failed and Obesity, Morbid, run by Antalya Training and Research Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kerem İnanoğlu, MD (+902422494400, kinanoglu@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubation time (time frame: through study completion, an average of 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06405672, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in